Study shows gene 'switches' can be edited to influence inflammation

Controlling the activity of specific genes in the laboratory through the editing of their epigenetic marks is now a reality thanks to the CRISPR technology. A team from the Josep Carreras Leukemia Research Institute has demonstrated that it is possible to precisely control the methylation status of one of the key genes involved in controlling the inflammatory response (IL1RN), thereby modifying how the cell responds to external stimuli. With this finding, the development of innovative therapies based on epigenome editing to tackle inflammatory diseases, including myeloid leukemia, is one step closer.
š Full Story

The Stoner 63 - The Navy SEALās Favorite Light Machine Gun
- David Sacks and the blurred lines of government service - Connie Loizos
- Moderna says mRNA flu vaccine sailed through trial, beating standard shot - Beth Mole
- Terminator's Forgotten First Attempt To Save Itself - Joshua Tyler
- This Smart Money Move Can Save Investors 100 Hours a Year
- Channel 5ās Murder Most Puzzling Is the Ultimate Guessing Game for Cosy Crime Lovers - Liam Dearden
- Trump Administration Rejects WHO Pandemic Regulations

This Solar Panel is ILLEGAL (except in Utah)
- The best smartphones to buy in 2025 - Cherlynn Low,Sam Rutherford
- Scientists develop new tool to identify NF1 cognitive signs earlier
- Voter Rolls Should Be Smaller, Not Bigger
- Amazonās AI push is undermining its sustainability goals - Daniel Cooper
- 11 Nuts and Seeds That Will Help Boost Your Magnesium Levels Naturally - Jillian Kubala, RD
- Why Cockroaches Are Dangerous to Your Health - Sarah Bradley